Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Comacchio

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Antibodies (Basel, Switzerland)|April 24, 2023
An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic LesionsEleonora Prodi, Claudia Comacchio, Ettore Gilardoni, et al.
Antibody Therapeutics|November 11, 2025
Generation and characterization of novel high-affinity fully human antibodies targeting prostate-specific membrane antigen and prostatic acid phosphataseClaudia Comacchio, Stefanie K Pfister, Domenico Ravazza, et al.
Chemmedchem|August 5, 2022
Isolation of a Natural Killer Group 2D Small-Molecule Ligand from DNA-Encoded Chemical LibrariesSheila Dakhel, Andrea Galbiati, Francesca Migliorini, et al.
Bioconjugate Chemistry|July 4, 2024
Permutational Encoding Strategy Accelerates HIT Validation from Single-Stranded DNA-Encoded LibrariesSara Puglioli, Mosè Fabbri, Claudia Comacchio, et al.
Journal for Immunotherapy of Cancer|May 11, 2025
Combinatorial treatment with upadacitinib abrogates systemic toxicity of a tumor-targeted IL-2 fusion proteinGiulia Rotta, Eleonora Prodi, Frauke Seehusen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Antibodies (Basel, Switzerland)|April 24, 2023
An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic LesionsEleonora Prodi, Claudia Comacchio, Ettore Gilardoni, et al.
Antibody Therapeutics|November 11, 2025
Generation and characterization of novel high-affinity fully human antibodies targeting prostate-specific membrane antigen and prostatic acid phosphataseClaudia Comacchio, Stefanie K Pfister, Domenico Ravazza, et al.
Chemmedchem|August 5, 2022
Isolation of a Natural Killer Group 2D Small-Molecule Ligand from DNA-Encoded Chemical LibrariesSheila Dakhel, Andrea Galbiati, Francesca Migliorini, et al.
Bioconjugate Chemistry|July 4, 2024
Permutational Encoding Strategy Accelerates HIT Validation from Single-Stranded DNA-Encoded LibrariesSara Puglioli, Mosè Fabbri, Claudia Comacchio, et al.
Journal for Immunotherapy of Cancer|May 11, 2025
Combinatorial treatment with upadacitinib abrogates systemic toxicity of a tumor-targeted IL-2 fusion proteinGiulia Rotta, Eleonora Prodi, Frauke Seehusen, et al.
Pageof 1